Deposit Contracts to Increase Accessibility of a Contingency Management Intervention to Reduce Problematic Drinking

NCT ID: NCT05837611

Last Updated: 2023-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-10

Study Completion Date

2024-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine the effects of an incentive-based intervention (for reducing alcohol use) that would be sustainable, easily accessible intervention using remote alcohol monitoring and deposit contracts, targeting individuals who would not be reached by more traditional forms of treatment due to barriers such as time constraints, attitudes, and stigma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Deposit contracts are effective at treating a wide variety of problems: smoking cessation, weight loss, and increasing physical activity. Despite the promise of deposit contracts, few earlier studies targeted problem drinking, since doing so required burdensome frequent monitoring - now overcome by remote alcohol monitoring. Earlier work relied on self- and collateral reports, breath alcohol concentrations during clinic visits, or an indirect non-specific marker of alcohol use. Despite these difficulties, earlier studies of deposit contracts were encouraging, with notable increases in: therapy participation; retention ; and abstinence duration compared to previous reports. Collectively, these studies show the potential of deposit contracts to reduce problem drinking but provide only limited evidence of its effectiveness. Still, these studies, and our recent success using contingency management with remote alcohol monitoring, provide a compelling rationale for examining whether a deposit contract program might provide a feasible, effective, and accessible way of helping people reduce drinking. Though there is limited systematic research on deposit contracts, deposit contract programs for various problems are widely available and have proven quite attractive. For example, a deposit contract weight loss website, has over 887,000 users with $62M in incentives paid. However, it is unclear if deposit contracts would be acceptable (and therefore feasible) to individuals interested in reducing their problem drinking. Therefore, we feel that the proposed deposit contract intervention utilizing remote alcohol monitoring could be a widely available and acceptable intervention for problem drinking for three reasons: (1) because of the effectiveness and convenience of our contingency management intervention using remote alcohol monitoring; (2) because of the widespread success of other deposit contract programs like DietBetã; and (3) because the potentially increased attractiveness and effectiveness of an intervention that can return an amount greater than the deposit. The adoption of a deposit contract intervention plus remote alcohol monitoring will only be accelerated by the "FitBit"-style alcohol monitoring devices being developed by many companies (we are currently independently evaluating one such device). However, making deposit contracts widely available will need evidence of their effectiveness, which requires large randomized controlled trials. The purpose of this R21 application is to develop this evidence by demonstrating that deposit contracts with remote alcohol monitoring are feasible and provide evidence of effectiveness needed to design and justify future studies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Abuse Alcohol Intervention Transdermal Alcohol Monitoring Contingency Management Deposit Contract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Monitoring Group Only

Individuals in the Monitoring only group will be required to put down a 200$ deposit but will earn it back non-contingently by attending the weekly study meetings. They will be monitored using the Transdermal Alcohol Monitoring device, but will not be required to meet any Alcohol reduction goals to earn their deposit back.

Group Type ACTIVE_COMPARATOR

Transdermal Alcohol Monitoring

Intervention Type OTHER

Using a SCRAM-Cam device participants will be monitored for their alcohol use.

Deposit Contract Group

Individuals in the Deposit COntract group will be required to put down a 200$ deposit but will earn it back, as well as a bonus, contingently for meeting alcohol reduction requirements. For this study, this is counted as having a Transdermal Alcohol COntent below equal to .02 g/dl. They will be monitored using the Transdermal Alcohol Monitoring device.

Group Type EXPERIMENTAL

Deposit Contract

Intervention Type BEHAVIORAL

A deposit contract requires individuals to put down money that is earned back contingently upon meeting their goals.

Transdermal Alcohol Monitoring

Intervention Type OTHER

Using a SCRAM-Cam device participants will be monitored for their alcohol use.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Deposit Contract

A deposit contract requires individuals to put down money that is earned back contingently upon meeting their goals.

Intervention Type BEHAVIORAL

Transdermal Alcohol Monitoring

Using a SCRAM-Cam device participants will be monitored for their alcohol use.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at least 21 years of age
* report \> 8 heavy drinking episodes during the last 28 days
* want to reduce their alcohol use
* are willing to wear a transdermal alcohol monitor
* own a smartphone
* are willing and able to deposit $200
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas Health Science Center at San Antonio

OTHER

Sponsor Role collaborator

University of North Texas, Denton, TX

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Of North Texas

Denton, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jamie R Pogue

Role: CONTACT

9403698308

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jamie R Pogue, BA

Role: primary

940-369-8308

References

Explore related publications, articles, or registry entries linked to this study.

Bigelow G, Strickler D, Liebson I, Griffiths R. Maintaining disulfiram ingestion among outpatient alcoholics: a security-deposit contingency contracting procedure. Behav Res Ther. 1976;14(5):378-81. doi: 10.1016/0005-7967(76)90028-0. No abstract available.

Reference Type BACKGROUND
PMID: 971213 (View on PubMed)

Burns RJ, Rothman AJ. Comparing Types of Financial Incentives to Promote Walking: An Experimental Test. Appl Psychol Health Well Being. 2018 Jul;10(2):193-214. doi: 10.1111/aphw.12126. Epub 2018 Apr 19.

Reference Type BACKGROUND
PMID: 29671957 (View on PubMed)

Dallery J, Raiff BR, Grabinski MJ, Marsch LA. Technology-Based Contingency Management in the Treatment of Substance-Use Disorders. Perspect Behav Sci. 2019 Jul 9;42(3):445-464. doi: 10.1007/s40614-019-00214-1. eCollection 2019 Sep.

Reference Type BACKGROUND
PMID: 31976444 (View on PubMed)

Ersner-Hershfield SM, Connors GJ, Maisto SA. Clinical and experimental utility of refundable deposits. Behav Res Ther. 1981;19(5):455-7. doi: 10.1016/0005-7967(81)90137-6. No abstract available.

Reference Type BACKGROUND
PMID: 7316923 (View on PubMed)

Jarvis BP, Dallery J. Internet-based self-tailored deposit contracts to promote smoking reduction and abstinence. J Appl Behav Anal. 2017 Apr;50(2):189-205. doi: 10.1002/jaba.377. Epub 2017 Feb 17.

Reference Type BACKGROUND
PMID: 28211949 (View on PubMed)

Paxton R. The effects of a deposit contract as a component in a behavioural programme for stopping smoking. Behav Res Ther. 1980;18(1):45-50. doi: 10.1016/0005-7967(80)90068-6. No abstract available.

Reference Type BACKGROUND
PMID: 7369987 (View on PubMed)

Pomerleau O, Pertschuk M, Adkins D, Brady JP. A comparison of behavioral and traditional treatment for middle-income problem drinkers. J Behav Med. 1978 Jun;1(2):187-200. doi: 10.1007/BF00846639.

Reference Type BACKGROUND
PMID: 756475 (View on PubMed)

Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008 Dec 10;300(22):2631-7. doi: 10.1001/jama.2008.804.

Reference Type BACKGROUND
PMID: 19066383 (View on PubMed)

White JS, Dow WH, Rungruanghiranya S. Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand. Am J Prev Med. 2013 Nov;45(5):533-42. doi: 10.1016/j.amepre.2013.06.020.

Reference Type BACKGROUND
PMID: 24139765 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brief Intervention for Heavy Drinkers
NCT00728767 COMPLETED PHASE3
Alcohol and Employment
NCT01416103 COMPLETED NA